CLINICAL TRIALS
Stephan Tippelt, R. Mikasch, Monika Warmuth‐Metz, Torsten Pietsch et autres
BACKGROUND: In recurrent neuroectodermal brain tumors leptomeningeal disease manifestation was observed in about 50 to 75% of patients.The role and efficacy of intrathecal therapy in these patients is unclear.As the systemic administration of etoposide is efficacious in brain tumors a phase II …
fr, de, us (code pays fourni par la source)